{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T22:27:22Z","timestamp":1793312842629,"version":"4.5.0"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,8,16]],"date-time":"2022-08-16T00:00:00Z","timestamp":1660608000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,8,16]],"date-time":"2022-08-16T00:00:00Z","timestamp":1660608000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000009","name":"Foundation for the National Institutes of Health","doi-asserted-by":"publisher","award":["RF1, AG051538"],"award-info":[{"award-number":["RF1, AG051538"]}],"id":[{"id":"10.13039\/100000009","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Brain-derived neurotrophic factor (BDNF) and its tropomyosin-related kinase B receptor (TrkB) are expressed in human osteoblasts and mediate fracture healing. BDNF\/TrkB signaling activates Akt that phosphorylates and inhibits asparagine endopeptidase (AEP), which regulates the differentiation fate of human bone marrow stromal cells (hBMSC) and is altered in postmenopausal osteoporosis. Here we show that R13, a small molecular TrkB receptor agonist prodrug, inhibits AEP and promotes bone formation. Though both receptor activator of nuclear factor kappa-\u0392 ligand (RANK-L) and osteoprotegerin (OPG) induced by ovariectomy (OVX) remain comparable between WT and BDNF+\/\u2212 mice, R13 treatment significantly elevates OPG in both mice without altering RANKL, blocking trabecular bone loss. Strikingly, both R13 and anti-RANK-L exhibit equivalent therapeutic efficacy. Moreover, OVX increases RANK-L and OPG in WT and AEP KO mice with RANK-L\/OPG ratio lower in the latter than the former, attenuating bone turnover. 7,8-DHF, released from R13, activates TrkB and its downstream effector CREB, which is critical for OPG augmentation. Consequently, 7,8-DHF represses C\/EBP\u03b2\/AEP pathway, inhibiting RANK-L-induced RAW264.7 osteoclastogenesis. Therefore, our findings support that R13 exerts its therapeutic efficacy toward osteoporosis via inhibiting AEP and escalating OPG.<\/jats:p>","DOI":"10.1038\/s41467-022-32435-5","type":"journal-article","created":{"date-parts":[[2022,8,16]],"date-time":"2022-08-16T12:03:16Z","timestamp":1660651396000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":46,"title":["A TrkB agonist prodrug prevents bone loss via inhibiting asparagine endopeptidase and increasing osteoprotegerin"],"prefix":"10.1038","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2221-5972","authenticated-orcid":false,"given":"Jing","family":"Xiong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6196-0510","authenticated-orcid":false,"given":"Jianming","family":"Liao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xia","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhaohui","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"Adams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6077-8250","authenticated-orcid":false,"given":"Roberto","family":"Pacifici","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7657-8154","authenticated-orcid":false,"given":"Keqiang","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,8,16]]},"reference":[{"key":"32435_CR1","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1146\/annurev.neuro.24.1.677","volume":"24","author":"EJ Huang","year":"2001","unstructured":"Huang, E. J. & Reichardt, L. F. Neurotrophins: roles in neuronal development and function. Annu. Rev. Neurosci. 24, 677\u2013736 (2001).","journal-title":"Annu. Rev. Neurosci."},{"key":"32435_CR2","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1016\/S0959-4388(00)00092-1","volume":"10","author":"DR Kaplan","year":"2000","unstructured":"Kaplan, D. R. & Miller, F. D. Neurotrophin signal transduction in the nervous system. Curr. Opin. Neurobiol. 10, 381\u2013391 (2000).","journal-title":"Curr. Opin. Neurobiol."},{"key":"32435_CR3","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1016\/0736-5748(94)90048-5","volume":"12","author":"M Cartwright","year":"1994","unstructured":"Cartwright, M., Mikheev, A. M. & Heinrich, G. Expression of neurotrophin genes in human fibroblasts: differential regulation of the brain-derived neurotrophic factor gene. Int. J. Dev. Neurosci. 12, 685\u2013693 (1994).","journal-title":"Int. J. Dev. Neurosci."},{"key":"32435_CR4","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1016\/S0002-9440(10)65287-X","volume":"154","author":"E Labouyrie","year":"1999","unstructured":"Labouyrie, E. et al. Expression of neurotrophins and their receptors in human bone marrow. Am. J. Pathol. 154, 405\u2013415 (1999).","journal-title":"Am. J. Pathol."},{"key":"32435_CR5","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.1007\/s00296-013-2943-5","volume":"34","author":"AP Simao","year":"2014","unstructured":"Simao, A. P. et al. Involvement of BDNF in knee osteoarthritis: the relationship with inflammation and clinical parameters. Rheumatol. Int. 34, 1153\u20131157 (2014).","journal-title":"Rheumatol. Int."},{"key":"32435_CR6","doi-asserted-by":"publisher","first-page":"16259","DOI":"10.1074\/jbc.M800668200","volume":"283","author":"M Kajiya","year":"2008","unstructured":"Kajiya, M. et al. Brain-derived neurotrophic factor stimulates bone\/cementum-related protein gene expression in cementoblasts. J. Biol. Chem. 283, 16259\u201316267 (2008).","journal-title":"J. Biol. Chem."},{"key":"32435_CR7","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1016\/j.aanat.2014.06.001","volume":"196","author":"O Kilian","year":"2014","unstructured":"Kilian, O. et al. BDNF and its TrkB receptor in human fracture healing. Ann. Anat. 196, 286\u2013295 (2014).","journal-title":"Ann. Anat."},{"key":"32435_CR8","doi-asserted-by":"publisher","first-page":"e0169201","DOI":"10.1371\/journal.pone.0169201","volume":"12","author":"H Ida-Yonemochi","year":"2017","unstructured":"Ida-Yonemochi, H., Yamada, Y., Yoshikawa, H. & Seo, K. Locally produced BDNF promotes sclerotic change in alveolar bone after nerve injury. PLoS One 12, e0169201 (2017).","journal-title":"PLoS One"},{"key":"32435_CR9","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.biochi.2015.09.022","volume":"122","author":"E Dall","year":"2016","unstructured":"Dall, E. & Brandstetter, H. Structure and function of legumain in health and disease. Biochimie 122, 126\u2013150 (2016).","journal-title":"Biochimie"},{"key":"32435_CR10","doi-asserted-by":"publisher","first-page":"27747","DOI":"10.1074\/jbc.274.39.27747","volume":"274","author":"SJ Choi","year":"1999","unstructured":"Choi, S. J. et al. Identification of human asparaginyl endopeptidase (legumain) as an inhibitor of osteoclast formation and bone resorption. J. Biol. Chem. 274, 27747\u201327753 (1999).","journal-title":"J. Biol. Chem."},{"key":"32435_CR11","doi-asserted-by":"publisher","first-page":"1804","DOI":"10.1359\/jbmr.2001.16.10.1804","volume":"16","author":"SJ Choi","year":"2001","unstructured":"Choi, S. J., Kurihara, N., Oba, Y. & Roodman, G. D. Osteoclast inhibitory peptide 2 inhibits osteoclast formation via its C-terminal fragment. J. Bone Min. Res. 16, 1804\u20131811 (2001).","journal-title":"J. Bone Min. Res."},{"key":"32435_CR12","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/j.stemcr.2017.01.003","volume":"8","author":"A Jafari","year":"2017","unstructured":"Jafari, A. et al. Legumain regulates differentiation fate of human bone marrow stromal cells and is altered in postmenopausal osteoporosis. Stem Cell Rep. 8, 373\u2013386 (2017).","journal-title":"Stem Cell Rep."},{"key":"32435_CR13","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1038\/sj.gt.3303067","volume":"15","author":"BM Abdallah","year":"2008","unstructured":"Abdallah, B. M. & Kassem, M. Human mesenchymal stem cells: from basic biology to clinical applications. Gene Ther. 15, 109\u2013116 (2008).","journal-title":"Gene Ther."},{"key":"32435_CR14","doi-asserted-by":"publisher","first-page":"3876","DOI":"10.1073\/pnas.0912531107","volume":"107","author":"SW Jang","year":"2010","unstructured":"Jang, S. W. et al. N-acetylserotonin activates TrkB receptor in a circadian rhythm. Proc. Natl Acad. Sci. U.S.A. 107, 3876\u20133881 (2010).","journal-title":"Proc. Natl Acad. Sci. U.S.A."},{"key":"32435_CR15","doi-asserted-by":"publisher","first-page":"8274","DOI":"10.1021\/jm101206p","volume":"53","author":"X Liu","year":"2010","unstructured":"Liu, X. et al. A synthetic 7,8-dihydroxyflavone derivative promotes neurogenesis and exhibits potent antidepressant effect. J. Med. Chem. 53, 8274\u20138286 (2010).","journal-title":"J. Med. Chem."},{"key":"32435_CR16","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/s40035-015-0048-7","volume":"5","author":"C Liu","year":"2016","unstructured":"Liu, C., Chan, C. B. & Ye, K. 7,8-dihydroxyflavone, a small molecular TrkB agonist, is useful for treating various BDNF-implicated human disorders. Transl. Neurodegener. 5, 2 (2016).","journal-title":"Transl. Neurodegener."},{"key":"32435_CR17","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1038\/npp.2013.243","volume":"39","author":"Z Zhang","year":"2014","unstructured":"Zhang, Z. et al. 7,8-dihydroxyflavone prevents synaptic loss and memory deficits in a mouse model of Alzheimer\u2019s disease. Neuropsychopharmacology 39, 638\u2013650 (2014).","journal-title":"Neuropsychopharmacology"},{"key":"32435_CR18","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1038\/npp.2011.191","volume":"37","author":"L Devi","year":"2012","unstructured":"Devi, L. & Ohno, M. 7,8-dihydroxyflavone, a small-molecule TrkB agonist, reverses memory deficits and BACE1 elevation in a mouse model of Alzheimer\u2019s disease. Neuropsychopharmacology 37, 434\u2013444 (2012).","journal-title":"Neuropsychopharmacology"},{"key":"32435_CR19","doi-asserted-by":"publisher","first-page":"e91453","DOI":"10.1371\/journal.pone.0091453","volume":"9","author":"NA Castello","year":"2014","unstructured":"Castello, N. A. et al. 7,8-Dihydroxyflavone, a small molecule TrkB agonist, improves spatial memory and increases thin spine density in a mouse model of Alzheimer's disease-like neuronal loss. PLoS One 9, e91453 (2014).","journal-title":"PLoS One"},{"key":"32435_CR20","doi-asserted-by":"publisher","unstructured":"Cikla, U. et al. ERalpha signaling is required for TrkB-mediated hippocampal neuroprotection in female neonatal mice after hypoxic-ischemic encephalopathy(1,2,3). eNeuro 3, https:\/\/doi.org\/10.1523\/ENEURO.0025-15.2015 (2016).","DOI":"10.1523\/ENEURO.0025-15.2015"},{"key":"32435_CR21","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1073\/pnas.1718683115","volume":"115","author":"C Chen","year":"2018","unstructured":"Chen, C. et al. The prodrug of 7,8-dihydroxyflavone development and therapeutic efficacy for treating Alzheimer\u2019s disease. Proc. Natl Acad. Sci. U.S.A. 115, 578\u2013583 (2018).","journal-title":"Proc. Natl Acad. Sci. U.S.A."},{"key":"32435_CR22","doi-asserted-by":"publisher","first-page":"eaba0466","DOI":"10.1126\/sciadv.aba0466","volume":"6","author":"C Chen","year":"2020","unstructured":"Chen, C. et al. Gut dysbiosis contributes to amyloid pathology, associated with C\/EBPbeta\/AEP signaling activation in Alzheimer\u2019s disease mouse model. Sci. Adv. 6, eaba0466 (2020).","journal-title":"Sci. Adv."},{"key":"32435_CR23","doi-asserted-by":"publisher","first-page":"169","DOI":"10.3389\/fncel.2019.00169","volume":"13","author":"E Ren","year":"2019","unstructured":"Ren, E. et al. Functional and structural impairments in the perirhinal cortex of a mouse model of CDKL5 deficiency disorder are rescued by a TrkB agonist. Front Cell Neurosci. 13, 169 (2019).","journal-title":"Front Cell Neurosci."},{"key":"32435_CR24","doi-asserted-by":"publisher","unstructured":"Wang, Z. H. et al. BDNF inhibits neurodegenerative disease-associated asparaginyl endopeptidase activity via phosphorylation by AKT. JCI Insight 3, https:\/\/doi.org\/10.1172\/jci.insight.99007 (2018).","DOI":"10.1172\/jci.insight.99007"},{"key":"32435_CR25","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-04120-z","volume":"9","author":"ZH Wang","year":"2018","unstructured":"Wang, Z. H. et al. C\/EBPbeta regulates delta-secretase expression and mediates pathogenesis in mouse models of Alzheimer\u2019s disease. Nat. Commun. 9, 1784 (2018).","journal-title":"Nat. Commun."},{"key":"32435_CR26","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1016\/j.celrep.2019.06.054","volume":"28","author":"ZH Wang","year":"2019","unstructured":"Wang, Z. H. et al. Deficiency in BDNF\/TrkB neurotrophic activity stimulates delta-secretase by upregulating C\/EBPbeta in Alzheimer\u2019s disease. Cell Rep. 28, 655\u2013669 e655 (2019).","journal-title":"Cell Rep."},{"key":"32435_CR27","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1016\/S0140-6736(18)32112-3","volume":"393","author":"JE Compston","year":"2019","unstructured":"Compston, J. E., McClung, M. R. & Leslie, W. D. Osteoporosis. Lancet 393, 364\u2013376 (2019).","journal-title":"Lancet"},{"key":"32435_CR28","doi-asserted-by":"publisher","first-page":"27571","DOI":"10.1074\/jbc.M114.562561","volume":"289","author":"X Liu","year":"2014","unstructured":"Liu, X. et al. Biochemical and biophysical investigation of the brain-derived neurotrophic factor mimetic 7,8-dihydroxyflavone in the binding and activation of the TrkB receptor. J. Biol. Chem. 289, 27571\u201327584 (2014).","journal-title":"J. Biol. Chem."},{"key":"32435_CR29","doi-asserted-by":"publisher","first-page":"11256","DOI":"10.1021\/bi00035a035","volume":"34","author":"JM Windisch","year":"1995","unstructured":"Windisch, J. M., Marksteiner, R., Lang, M. E., Auer, B. & Schneider, R. Brain-derived neurotrophic factor, neurotrophin-3, and neurotrophin-4 bind to a single leucine-rich motif of TrkB. Biochemistry 34, 11256\u201311263 (1995).","journal-title":"Biochemistry"},{"key":"32435_CR30","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/j.chembiol.2015.02.003","volume":"22","author":"CB Chan","year":"2015","unstructured":"Chan, C. B. et al. Activation of muscular TrkB by its small molecular agonist 7,8-dihydroxyflavone sex-dependently regulates energy metabolism in diet-induced obese mice. Chem. Biol. 22, 355\u2013368 (2015).","journal-title":"Chem. Biol."},{"key":"32435_CR31","doi-asserted-by":"publisher","first-page":"48868","DOI":"10.1074\/jbc.M208494200","volume":"277","author":"Q Fu","year":"2002","unstructured":"Fu, Q., Jilka, R. L., Manolagas, S. C. & O\u2019Brien, C. A. Parathyroid hormone stimulates receptor activator of NFkappa B ligand and inhibits osteoprotegerin expression via protein kinase A activation of cAMP-response element-binding protein. J. Biol. Chem. 277, 48868\u201348875 (2002).","journal-title":"J. Biol. Chem."},{"key":"32435_CR32","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1002\/jcb.21414","volume":"103","author":"T Kondo","year":"2008","unstructured":"Kondo, T., Kitazawa, R., Yamaguchi, A. & Kitazawa, S. Dexamethasone promotes osteoclastogenesis by inhibiting osteoprotegerin through multiple levels. J. Cell Biochem. 103, 335\u2013345 (2008).","journal-title":"J. Cell Biochem."},{"key":"32435_CR33","doi-asserted-by":"publisher","first-page":"11969","DOI":"10.1002\/jcp.27852","volume":"234","author":"C Song","year":"2019","unstructured":"Song, C. et al. Evaluation of efficacy on RANKL induced osteoclast from RAW264.7 cells. J. Cell Physiol. 234, 11969\u201311975 (2019).","journal-title":"J. Cell Physiol."},{"key":"32435_CR34","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.bonr.2014.12.002","volume":"2","author":"N Tokuyama","year":"2015","unstructured":"Tokuyama, N. et al. Individual and combining effects of anti-RANKL monoclonal antibody and teriparatide in ovariectomized mice. Bone Rep. 2, 1\u20137 (2015).","journal-title":"Bone Rep."},{"key":"32435_CR35","doi-asserted-by":"publisher","first-page":"5394","DOI":"10.1210\/en.2012-1378","volume":"153","author":"C Camerino","year":"2012","unstructured":"Camerino, C. et al. Central depletion of brain-derived neurotrophic factor in mice results in high bone mass and metabolic phenotype. Endocrinology 153, 5394\u20135405 (2012).","journal-title":"Endocrinology"},{"key":"32435_CR36","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00198-007-0449-2","volume":"19","author":"B Mezuk","year":"2008","unstructured":"Mezuk, B., Eaton, W. W. & Golden, S. H. Depression and osteoporosis: epidemiology and potential mediating pathways. Osteoporos. Int 19, 1\u201312 (2008).","journal-title":"Osteoporos. Int"},{"key":"32435_CR37","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1359\/jbmr.070207","volume":"22","author":"N Charatcharoenwitthaya","year":"2007","unstructured":"Charatcharoenwitthaya, N., Khosla, S., Atkinson, E. J., McCready, L. K. & Riggs, B. L. Effect of blockade of TNF-alpha and interleukin-1 action on bone resorption in early postmenopausal women. J. Bone Min. Res. 22, 724\u2013729 (2007).","journal-title":"J. Bone Min. Res."},{"key":"32435_CR38","doi-asserted-by":"publisher","first-page":"29279","DOI":"10.1074\/jbc.273.45.29279","volume":"273","author":"V Poli","year":"1998","unstructured":"Poli, V. The role of C\/EBP isoforms in the control of inflammatory and native immunity functions. J. Biol. Chem. 273, 29279\u201329282 (1998).","journal-title":"J. Biol. Chem."},{"key":"32435_CR39","doi-asserted-by":"publisher","first-page":"101905","DOI":"10.1016\/j.pneurobio.2020.101905","volume":"198","author":"EH Ahn","year":"2021","unstructured":"Ahn, E. H. et al. BDNF and Netrin-1 repression by C\/EBPbeta in the gut triggers Parkinson\u2019s disease pathologies, associated with constipation and motor dysfunctions. Prog. Neurobiol. 198, 101905 (2021).","journal-title":"Prog. Neurobiol."},{"key":"32435_CR40","doi-asserted-by":"publisher","first-page":"10773","DOI":"10.1073\/pnas.1713969114","volume":"114","author":"SS Kang","year":"2017","unstructured":"Kang, S. S. et al. TrkB neurotrophic activities are blocked by alpha-synuclein, triggering dopaminergic cell death in Parkinson\u2019s disease. Proc. Natl Acad. Sci. USA 114, 10773\u201310778 (2017).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"32435_CR41","doi-asserted-by":"publisher","first-page":"9094","DOI":"10.1073\/pnas.1901348116","volume":"116","author":"J Xiang","year":"2019","unstructured":"Xiang, J. et al. Delta-secretase-cleaved Tau antagonizes TrkB neurotrophic signalings, mediating Alzheimer\u2019s disease pathologies. Proc. Natl Acad. Sci. U.S.A. 116, 9094\u20139102 (2019).","journal-title":"Proc. Natl Acad. Sci. U.S.A."},{"key":"32435_CR42","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1111\/j.1399-302X.2009.00529.x","volume":"24","author":"T Suda","year":"2009","unstructured":"Suda, T. et al. Regulatory roles of beta-catenin and AP-1 on osteoprotegerin production in interleukin-1alpha-stimulated periodontal ligament cells. Oral. Microbiol. Immunol. 24, 384\u2013389 (2009).","journal-title":"Oral. Microbiol. Immunol."},{"key":"32435_CR43","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1038\/cr.2014.4","volume":"24","author":"L Zhao","year":"2014","unstructured":"Zhao, L. et al. Structural analysis of asparaginyl endopeptidase reveals the activation mechanism and a reversible intermediate maturation stage. Cell Res. 24, 344\u2013358 (2014).","journal-title":"Cell Res."},{"key":"32435_CR44","doi-asserted-by":"publisher","first-page":"3018","DOI":"10.1172\/JCI128521","volume":"129","author":"MM Zaiss","year":"2019","unstructured":"Zaiss, M. M., Jones, R. M., Schett, G. & Pacifici, R. The gut-bone axis: how bacterial metabolites bridge the distance. J. Clin. Investig. 129, 3018\u20133028 (2019).","journal-title":"J. Clin. Investig."},{"key":"32435_CR45","doi-asserted-by":"publisher","first-page":"101149","DOI":"10.1016\/j.molmet.2020.101149","volume":"45","author":"Z Zhao","year":"2021","unstructured":"Zhao, Z. et al. Crosstalk between the muscular estrogen receptor alpha and BDNF\/TrkB signaling alleviates metabolic syndrome via 7,8-dihydroxyflavone in female mice. Mol. Metab. 45, 101149 (2021).","journal-title":"Mol. Metab."},{"key":"32435_CR46","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/j.cell.2006.01.051","volume":"125","author":"L Sun","year":"2006","unstructured":"Sun, L. et al. FSH directly regulates bone mass. Cell 125, 247\u2013260 (2006).","journal-title":"Cell"},{"key":"32435_CR47","doi-asserted-by":"publisher","first-page":"14574","DOI":"10.1073\/pnas.1212806109","volume":"109","author":"LL Zhu","year":"2012","unstructured":"Zhu, L. L. et al. Blocking antibody to the beta-subunit of FSH prevents bone loss by inhibiting bone resorption and stimulating bone synthesis. Proc. Natl Acad. Sci. U.S.A. 109, 14574\u201314579 (2012).","journal-title":"Proc. Natl Acad. Sci. U.S.A."},{"key":"32435_CR48","doi-asserted-by":"publisher","first-page":"33194","DOI":"10.1074\/jbc.M302742200","volume":"278","author":"K Shirahama-Noda","year":"2003","unstructured":"Shirahama-Noda, K. et al. Biosynthetic processing of cathepsins and lysosomal degradation are abolished in asparaginyl endopeptidase-deficient mice. J. Biol. Chem. 278, 33194\u201333199 (2003).","journal-title":"J. Biol. Chem."},{"key":"32435_CR49","doi-asserted-by":"publisher","first-page":"2049","DOI":"10.1172\/JCI86062","volume":"126","author":"JY Li","year":"2016","unstructured":"Li, J. Y. et al. Sex steroid deficiency-associated bone loss is microbiota dependent and prevented by probiotics. J. Clin. Investig. 126, 2049\u20132063 (2016).","journal-title":"J. Clin. Investig."},{"key":"32435_CR50","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1016\/j.cmet.2015.09.012","volume":"22","author":"JY Li","year":"2015","unstructured":"Li, J. Y. et al. IL-17A is increased in humans with primary hyperparathyroidism and mediates PTH-induced bone loss in mice. Cell Metab. 22, 799\u2013810 (2015).","journal-title":"Cell Metab."},{"key":"32435_CR51","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1002\/jbmr.1805","volume":"28","author":"DW Dempster","year":"2013","unstructured":"Dempster, D. W. et al. Standardized nomenclature, symbols, and units for bone histomorphometry: a 2012 update of the report of the ASBMR Histomorphometry Nomenclature Committee. J. Bone Min. Res. 28, 2\u201317 (2013).","journal-title":"J. Bone Min. Res."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-022-32435-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-022-32435-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-022-32435-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,24]],"date-time":"2022-11-24T13:28:11Z","timestamp":1669296491000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-022-32435-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,16]]},"references-count":51,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["32435"],"URL":"https:\/\/doi.org\/10.1038\/s41467-022-32435-5","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-412961\/v1","asserted-by":"object"}]},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,8,16]]},"assertion":[{"value":"11 April 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 July 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 August 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"4820"}}